Antitrust Suit Against Amarin Pharma Forges Ahead
A New Jersey judge largely refused to toss a lawsuit accusing Amarin Pharma of hoarding the active pharmaceutical ingredients needed to produce generic versions of its cardiovascular drug Vascepa, finding that...To view the full article, register now.
Already a subscriber? Click here to view full article